What is Humanity?
Headquartered in London, United Kingdom, Humanity operates a sophisticated mobile platform designed to quantify and slow the aging process. The application integrates diverse health metrics to offer personalized recommendations, effectively bridging the gap between clinical longevity research and consumer-facing wellness. As the company transitions from its initial development phase into a broader scaling trajectory, it remains focused on the intersection of artificial intelligence and human biology. The firm's market position is defined by its ability to translate intricate health data into tangible lifestyle adjustments, catering to a demographic increasingly concerned with long-term vitality and immune resilience.
How much funding has Humanity raised?
Humanity has raised a total of $5M across 2 funding rounds:
Angel/Seed
$2.5M
Angel/Seed
$2.5M
Angel/Seed (2020): $2.5M with participation from One Way Ventures and Esther Dyson
Angel/Seed (2021): $2.5M led by Seedcamp, Esther Dyson, Breega, Alexander Ljung, Taavet Hinrikus, Michael Acton-Smith, One Way Ventures, 7Percent Ventures, Robin Thurston, and Alex Tew
Key Investors in Humanity
Seedcamp
Seedcamp is a prominent venture capital firm that supports early-stage startups through investment, mentorship, and access to a vast global network, fostering the growth of Europe's future leaders.
Breega
Breega is a venture capital firm specializing in backing exceptional founders from pre-Seed to Series A+ across Digital, Climate, and Deep Tech sectors, providing both financial support and tactical operational expertise.
One Way Ventures
One Way Ventures is a specialized VC firm dedicated to supporting immigrant founders in building high-impact global companies, operating on the belief that borders should not limit human potential.
What's next for Humanity?
With the recent capital injection, Humanity is well-positioned to accelerate its product roadmap and expand its user base across international markets. The strategic focus will likely shift toward enhancing the platform's predictive modeling capabilities and deepening its integration with wearable health devices. By leveraging the expertise of its high-profile investor base, the company aims to solidify its infrastructure and refine its algorithmic accuracy. As the longevity market matures, Humanity's ability to maintain its competitive edge will depend on its capacity to scale its data-driven insights while navigating the evolving regulatory landscape of digital health and personalized medicine.
See full Humanity company page
